Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 29, 2011European Respiratory JournalOpen Access

Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRupak SinglaJCJosé A. CamineroAJAshish Jaiswal

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Singla et al. (2011) studied this question.

synapsesocial.com/papers/6aa17cd3408cd2a7443c7c4chttps://doi.org/10.1183/09031936.00076811
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment Outcomes among Patients with Extensively Drug‐Resistant Tuberculosis: Systematic Review and Meta‐Analysis2010 · 245 citations
  2. 2Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis2009 · 98 citations
  3. 3Comprehensive Treatment of Extensively Drug-Resistant Tuberculosis2008 · 402 citations
  4. 4Activities of Several Novel Oxazolidinones against <i>Mycobacterium tuberculosis</i> in a Murine Model1999 · 242 citations
  5. 5Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis2004 · 336 citations